Homepage Insights News & Events News

Medical Properties Trust investeert samen met Waterland Private Equity Investments in de Priory Group

Work highlight
Also in: English
30-12-2020
Loyens & Loeff adviseerde Medical Properties Trust bij de investering in de Priory Group als co-investeerder naast Waterland. Medical Properties Trust, Inc. ("MPT") (NYSE: MPW) is een sale and sale back transactie aangegaan voor een portefeuille van geselecteerde gedragsgezondheidsfaciliteiten van de toonaangevende Britse gedragsgezondheidsleverancier The Priory Group. De te betalen prijs voor de overname bedraagt in totaal £800 miljoen. In een verwante transactie verwierven filialen van Waterland Private Equity The Priory Group van Acadia Healthcare Inc. waar MPT optrad als mede-investeerder.
Linkedin icon Twiter icon Mail icon
Sectors & Markets
Life Sciences & Healthcare
Expertises
Corporate / M&A Transactional Tax
Linkedin icon Twiter icon Mail icon
Branding icon

Contact us

Eline de Ruijter
Eline de Ruijter
Senior Associate
Attorney at Law
Amsterdam
Noortje Crouwers
Noortje Crouwers
Senior Associate
Senior Deputy Civil Law Notary
Amsterdam
Gianluca Kreuze
Gianluca Kreuze
Partner
Attorney at Law
Amsterdam
Ivar van der Mark
Ivar van der Mark
Associate
Attorney at Law
Amsterdam
Ingrid Hijdra
Ingrid Hijdra
Senior Associate
Tax Adviser
Amsterdam
Roel Fluit
Roel Fluit
Partner
Attorney at Law
London
Return to previous slide
Go to next slide
Other recent news
  • Loyens & Loeff advised Foundever on its recapitalisation and refinancing
    20-08-2026
    Loyens & Loeff advised Foundever on its recapitalisation and refinancing
    Our Banking & Finance, Corporate and Tax teams advised Foundever on the Luxembourg and Dutch aspects of its significant recapitalisation and refinancing transaction.
    Work highlight
  • Living Capital Partners acquires a residential portfolio in Utrecht
    18-08-2026
    Living Capital Partners acquires a residential portfolio in Utrecht
    We advised Living Capital Partners (LCP) on the equity arrangements for its acquisition of a residential complex in Utrecht from a Dutch institutional investor.
    Work highlight
  • Sever Life Sciences agrees on the sale of the Nordic Group B.V. to Alfasigma
    14-08-2026
    Sever Life Sciences agrees on the sale of the Nordic Group B.V. to Alfasigma
    Our Corporate M&A and Tax teams advised Sever Life Sciences on its disposal of Nordic Group B.V., a European specialty pharmaceutical platform to Alfasigma.
    Work highlight
Logo Loyens & Loeff
Linkedin icon
Netherlands Belgium Luxembourg Switzerland
Legal & Privacy